Differential Transcriptomic Signatures of Small Airway Cell Cultures Derived from IPF and COVID-19-Induced Exacerbation of Interstitial Lung Disease

Katie Uhl,Shreya Paithankar,Dmitry Leshchiner,Tara E. Jager,Mohamed Abdelgied,Bhavna Dixit,Raya Marashdeh,Dewen Luo-Li,Kaylie Tripp,Angela M. Peraino,Maximiliano Tamae Kakazu,Cameron Lawson,Dave W. Chesla,Ningzhi Luo-Li,Edward T. Murphy,Jeremy Prokop,Bin Chen,Reda E. Girgis,Xiaopeng Li,Edward R. Murphy
DOI: https://doi.org/10.3390/cells12202501
IF: 6
2023-10-21
Cells
Abstract:Idiopathic pulmonary fibrosis (IPF) is a pathological condition wherein lung injury precipitates the deposition of scar tissue, ultimately leading to a decline in pulmonary function. Existing research indicates a notable exacerbation in the clinical prognosis of IPF patients following infection with COVID-19. This investigation employed bulk RNA-sequencing methodologies to describe the transcriptomic profiles of small airway cell cultures derived from IPF and post-COVID fibrosis patients. Differential gene expression analysis unveiled heightened activation of pathways associated with microtubule assembly and interferon signaling in IPF cell cultures. Conversely, post-COVID fibrosis cell cultures exhibited distinctive characteristics, including the upregulation of pathways linked to extracellular matrix remodeling, immune system response, and TGF-β1 signaling. Notably, BMP signaling levels were elevated in cell cultures derived from IPF patients compared to non-IPF control and post-COVID fibrosis samples. These findings underscore the molecular distinctions between IPF and post-COVID fibrosis, particularly in the context of signaling pathways associated with each condition. A better understanding of the underlying molecular mechanisms holds the promise of identifying potential therapeutic targets for future interventions in these diseases.
cell biology
What problem does this paper attempt to address?